Insider · CIK 0002134015
Donovan Michael Glancy
Files at COLL (COLLEGIUM PHARMACEUTICAL, INC). First filing -, latest -.
Donovan Michael Glancy files SEC Form 4 as director at COLL (COLLEGIUM PHARMACEUTICAL, INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Donovan Michael Glancy has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 14, 2026 | COLL COLLEGIUM PHARMACEUTICAL, INC | AGrant or award Common Stock | +17,482 | $0.00 | $0 | 17,482 | May 18, 2026 |
Questions about Donovan Michael Glancy
Answered from the filings on this page, as of the latest one.
Is Donovan Michael Glancy buying or selling?
Donovan Michael Glancy has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Donovan Michael Glancy's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Donovan Michael Glancy has 0.
Where does Donovan Michael Glancy file Form 4?
Donovan Michael Glancy has filed Form 4 at COLL (COLLEGIUM PHARMACEUTICAL, INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.